Gail Elizabeth Tomlinson

University Of Texas Sw Med Ctr/Dallas

$1,127,078

Attributed

$1,127,078

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $251.8K · FY2005–25

$500K$375K$250K$125K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$1,127,078 · 5

By mechanism

R21$390,575 · 1

R03$312,000 · 2

P50$261,295 · 1

P30$163,208 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Sw Med Ctr/Dallas

Same institution · by research overlap

Michael J Gale$70,921,035
Mamta K Jain$6,366,380
Ellen S Vitetta$11,813,406
William M Lee$28,967,272

Others in their field

Top investigators on “Genetic Markers”

David R. Weir · University Of Michigan At Ann Arbor$241,789,884
Peter B. Gilbert · Fred Hutchinson Cancer Center$146,111,713
David Heimbrook · Leidos Biomedical Research, Inc.$129,406,350
Randall J Bateman · Washington University$127,317,825
Lawrence Corey · Fred Hutchinson Cancer Center$100,712,139
Glenda E Gray · Wits Health Consortium (Pty), Ltd$100,712,139

Research focus

Genetic MarkersClinical ResearchCancer RiskHuman SubjectFamily GeneticsNeoplasm /Cancer GeneticsGenetic SusceptibilityBiomarkerHuman Genetic Material TagBenzopyrenediol EpoxideGenotypeAfrican AmericanBronchopulmonary DysplasiaGlutathione TransferaseGenetic PolymorphismLung NeoplasmsCytochrome P450CytogeneticsDna DamageBleomycinCaucasian AmericanChemical CarcinogenLoss Of HeterozygosityPreneoplastic State